Pigeon Corp (PGENY)
OTHER OTC:PGENY
Want to see PGENY full AI Analyst Report?
Top Page
Pigeon
(OTC:PGENY)
Select Model
Select Model
Rating:75Outperform
Price Target:
$3.00
â–²(15.83% Upside)
Action:UpgradedDate:02/18/26
The score is driven primarily by strong financial quality—especially an exceptionally conservative balance sheet and solid cash generation—tempered by margin/return pressure versus prior peak years. Technicals are only moderately supportive (short-term strength but still below longer-term averages), and valuation looks fair with a supportive dividend yield but a mid-range P/E.
Positive Factors
Conservative balance sheet
Exceptionally low leverage and steadily growing equity provide durable financial flexibility. This capital structure supports investment in R&D, distribution, dividends or buybacks, and provides resilience in downturns, enabling long-term strategic optionality and lower refinancing risk.
Negative Factors
Margin compression vs prior highs
Falling margins versus prior peaks suggest reduced operating leverage or higher cost pressure that can persist. Lower margin headroom limits reinvestment and ROE expansion, making earnings more sensitive to cost inflation and competitive pricing over the coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Exceptionally low leverage and steadily growing equity provide durable financial flexibility. This capital structure supports investment in R&D, distribution, dividends or buybacks, and provides resilience in downturns, enabling long-term strategic optionality and lower refinancing risk.
Read all positive factors
Pigeon (PGENY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.28B
Dividend Yield3.09%
Average Volume (3M)0.00
Price to Earnings (P/E)22.5
Beta (1Y)0.16
Revenue Growth6.28%
EPS Growth3.89%
CountryUS
Employees3,066
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)0.02
Shares Outstanding486,612,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio2.97
Price to Book (P/B)2.43
Price to Sales (P/S)1.76
P/FCF Ratio18.77
Enterprise Value/Market Cap132.29
Enterprise Value/Revenue1.59
Enterprise Value/Gross Profit3.17
Enterprise Value/Ebitda12.64
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Pigeon Business Overview & Revenue Model
Company Description
Pigeon Corporation manufactures, sells, imports, and exports baby and child-care products, maternity items, women's care products, home healthcare products, and elder care products in Japan and internationally. The company operates in four segment...
How the Company Makes Money
Pigeon generates revenue primarily through the sale of its wide range of baby and maternal care products. The company's revenue model is largely based on direct sales through retail channels, e-commerce platforms, and partnerships with hospitals a...
Pigeon Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
91
Very Positive
Cash Flow
80
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 106.59B | 114.46B | 104.17B | 94.46B | 94.92B | 93.08B |
| Gross Profit | 53.58B | 57.50B | 51.37B | 45.45B | 44.83B | 44.07B |
| EBITDA | 13.44B | 18.62B | 17.82B | 16.33B | 17.14B | 17.50B |
| Net Income | 9.42B | 8.99B | 8.37B | 7.42B | 8.58B | 8.79B |
Balance Sheet | ||||||
| Total Assets | 105.40B | 110.16B | 108.31B | 100.44B | 101.73B | 98.04B |
| Cash, Cash Equivalents and Short-Term Investments | 34.07B | 39.64B | 39.20B | 34.36B | 34.28B | 35.22B |
| Total Debt | 33.83M | 1.36B | 1.77B | 1.90B | 2.06B | 1.94B |
| Total Liabilities | 24.75B | 24.22B | 23.70B | 19.35B | 21.78B | 21.23B |
| Stockholders Equity | 78.09B | 82.97B | 81.14B | 77.58B | 76.69B | 73.88B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.76B | 12.03B | 8.87B | 7.65B | 5.00B |
| Operating Cash Flow | 0.00 | 13.69B | 14.28B | 14.52B | 13.21B | 10.89B |
| Investing Cash Flow | 0.00 | -3.30B | -1.14B | -5.47B | -5.66B | -5.59B |
| Financing Cash Flow | 0.00 | -11.34B | -10.64B | -10.26B | -9.67B | -8.69B |
Pigeon Technical Analysis
Positive
2.59
Price Trends
2.61
Positive
2.60
Positive
2.76
Negative
Market Momentum
0.02
Negative
61.27
Neutral
60.42
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PGENY, the sentiment is Positive. The current price of 2.59 is below the 20-day moving average (MA) of 2.59, below the 50-day MA of 2.61, and below the 200-day MA of 2.76, indicating a neutral trend. The MACD of 0.02 indicates Negative momentum. The RSI at 61.27 is Neutral, neither overbought nor oversold. The STOCH value of 60.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PGENY.
Pigeon Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $1.28B | 22.47 | 10.89% | 3.09% | 6.28% | 3.89% | |
70 Outperform | $22.99B | 25.51 | 17.16% | 1.38% | 2.22% | 29.40% | |
68 Neutral | $1.92B | 12.42 | 5.52% | 3.15% | -6.25% | 4.87% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
53 Neutral | $11.66B | 16.81 | 1502.49% | 5.05% | -3.69% | 10.26% | |
52 Neutral | $1.05B | -3.02 | -2.50% | 3.51% | -3.36% | -145.55% | |
51 Neutral | $1.73B | -10.96 | -10.89% | 7.76% | -4.11% | -14.23% |
* Consumer Defensive Sector Average
PGENY
Pigeon
2.68
-0.30
-10.11%
CHD
Church & Dwight
96.02
4.27
4.66%
CLX
Clorox
87.11
-45.97
-34.54%
NWL
Newell Brands
4.55
-0.39
-7.97%
SPB
Spectrum Brands Holdings
82.96
20.50
32.81%
EPC
Edgewell Personal Care
22.56
-7.18
-24.13%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.